menu
    • menu

    Company profile for Tenax Therapeutics

    NEW Drugs in Dev: 4
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We intend to identify and acquire innovative proprietary pharmaceutical products that represent high value commercial opportunities for the North American market. We do not intend to conduct basic research ourselves. The relative efficiency of our “search” strategy enables us to focus the majority of our resources on developing and commercializing innovative products that other companies have discovered. We intend to devel...
    We intend to identify and acquire innovative proprietary pharmaceutical products that represent high value commercial opportunities for the North American market. We do not intend to conduct basic research ourselves. The relative efficiency of our “search” strategy enables us to focus the majority of our resources on developing and commercializing innovative products that other companies have discovered. We intend to develop pharmaceutical products that meet significant unmet needs in North America.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Tenax TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    ONE Copley Parkway, Suite 490, Morrisville, NC 27560
    Telephone
    Telephone
    (919) 855-2100
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://tenaxthera.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/oxygen-biotherapeutics
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    RDD

    RDD

    Not Confirmed

    envelop Contact Supplier

    RDD

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Tenax Therapeutics Issues Inducement Grants Under Nasdaq Rule
    Tenax Therapeutics Issues Inducement Grants Under Nasdaq Rule

    08 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/08/3291325/12401/en/tenax-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4.html

    GLOBENEWSWIRE
    08 May 2026
    Share Share
    Tenax Therapeutics Names Timothy Healey as CCO
    Tenax Therapeutics Names Timothy Healey as CCO

    04 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/04/3286546/12401/en/tenax-therapeutics-appoints-timothy-healey-mba-as-chief-commercial-officer.html

    GLOBENEWSWIRE
    04 May 2026
    Share Share
    Tenax Pharma Reveals 2025 Financials And Corporate Progress
    Tenax Pharma Reveals 2025 Financials And Corporate Progress

    10 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/10/3252611/12401/en/Tenax-Therapeutics-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Provides-Corporate-Update.html

    GLOBENEWSWIRE
    10 Mar 2026
    Share Share
    Tenax Pharma To Join 2026 Leerink Partners Healthcare Conference
    Tenax Pharma To Join 2026 Leerink Partners Healthcare Conference

    03 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/03/3248191/12401/en/Tenax-Therapeutics-to-Participate-in-the-2026-Leerink-Partners-Global-Healthcare-Conference.html

    GLOBENEWSWIRE
    03 Mar 2026
    Share Share
    Tenax Therapeutics Joins Guggenheim Biotech Summit 2026
    Tenax Therapeutics Joins Guggenheim Biotech Summit 2026

    04 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/04/3231896/12401/en/Tenax-Therapeutics-to-Participate-in-the-Guggenheim-Emerging-Outlook-Biotech-Summit-2026.html

    GLOBENEWSWIRE
    04 Feb 2026
    Share Share
    Tenax Pharma Reveals Outcome Of Blinded Sample Size Evaluation
    Tenax Pharma Reveals Outcome Of Blinded Sample Size Evaluation

    17 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/17/3207055/12401/en/Tenax-Therapeutics-Announces-Result-of-Prespecifed-Blinded-Sample-Size-Assessment.html

    GLOBENEWSWIRE
    17 Dec 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search